Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K. S. Koblan
Farnesyltransferase Inhibitors: A New Class of Cancer Chemotherapeutics
Biochemical Society Transactions
Biochemistry
Related publications
The Potential of Farnesyltransferase Inhibitors as Cancer Chemotherapeutics
Annual Review of Pharmacology and Toxicology
Toxicology
Pharmacology
A Mutant Form of Human Protein Farnesyltransferase Exhibits Increased Resistance to Farnesyltransferase Inhibitors
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
New Targeted Therapies in Myelodysplastic Syndrome: The Role of Farnesyltransferase and Proteasome Inhibitors
BMC Proceedings
Biochemistry
Medicine
Genetics
Molecular Biology
Kinase Inhibitors: A New Class of Antirheumatic Drugs
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
High Affinity for Farnesyltransferase and Alternative Prenylation Contribute Individually to K-Ras4B Resistance to Farnesyltransferase Inhibitors
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Immune Response Checkpoint Inhibitors: New Risks of a New Class of Antitumor Agents
Safety and Risk of Pharmacotherapy
Alogliptin: A New Addition to the Class of DPP-4 Inhibitors
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
SAR Studies for a New Class of Antibacterial NAD Biosynthesis Inhibitors
Journal of Combinatorial Chemistry
“Reverse” Carbocyclic Fleximers: Synthesis of a New Class of Adenosine Deaminase Inhibitors
Nucleosides, Nucleotides and Nucleic Acids
Medicine
Biochemistry
Genetics
Molecular Medicine